Philip Morris International to Build Smoke-Free Product Facility in Germany
June 19 2017 - 8:30AM
Business Wire
Another step towards a smoke-free
future
- USD 320 million investment in new
Dresden facility
- 500 new jobs expected
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM)
announces plans to invest approximately USD 320 million in a new
high-tech facility in Dresden, Germany, to produce HEETS, the
tobacco units to be used with the electronic tobacco heating device
IQOS.
Construction of the 80,000 m2 facility is scheduled to begin in
late 2017. Once fully operational in early 2019, the factory is
expected to employ about 500 people.
IQOS and HEETS have been available for adult smokers in Germany
since June 2016, starting with pilot commercialization in Munich,
Frankfurt and Berlin. IQOS is currently available in key
cities in more than 25 markets around the world. Commenting on the
announcement, André Calantzopoulos, PMI’s Chief Executive Officer,
said:
“This investment represents another step towards a future in
which smoke-free products replace cigarettes. Already, over two
million people have given up smoking and switched to IQOS, and we
know this is just the beginning. We are fully committed to meet
smoker demand for potentially less harmful alternatives to
cigarettes.”
Frederic de Wilde, President of PMI’s European Union Region
added:
“We are encouraged by the successful launch of IQOS in Germany
and its performance in other European countries. Europe has become
a hub for PMI’s research, development and investment in better
alternatives to cigarettes.”
With this announcement, Germany will join a growing list of
countries where PMI manufactures tobacco units for IQOS, including
Italy and Switzerland. In addition, PMI recently announced the
conversion of the cigarette manufacturing facility of its affiliate
in Greece. By the end of 2018, PMI plans to have a total annual
installed capacity of heated tobacco units of approximately 100
billion units.
IQOS is one of four scientifically substantiated smoke-free
product platforms that PMI is developing to address adult smoker
demand for better alternatives to cigarettes.
Since 2008, PMI has hired more than 400 scientists and experts
and invested over USD 3 billion in research, product development
and scientific substantiation for smoke-free products. The company
openly shares its scientific methodologies and findings for
independent third-party review and verification, and has published
its research in over 200 articles and book chapters since 2011.
Results of scientific research conducted by PMI to date indicate
that IQOS is likely to reduce the risk of harm compared to
cigarette smoking, and is a better choice for those who would
otherwise continue to smoke.
Philip Morris International Inc.
Philip Morris International Inc. (PMI) is the world’s leading
international tobacco company, with six of the world's top 15
international brands and products sold in more than 180 markets. In
addition to the manufacture and sale of cigarettes, including
Marlboro, the number one global cigarette brand, and other tobacco
products, PMI is engaged in the development and commercialization
of reduced-risk products (RRPs). RRPs is the term PMI uses to refer
to products that present, are likely to present, or have the
potential to present less risk of harm to smokers who switch to
these products versus continued smoking. Through multidisciplinary
capabilities in product development, state-of-the-art facilities,
and industry-leading scientific substantiation, PMI aims to provide
an RRP portfolio that meets a broad spectrum of adult smoker
preferences and rigorous regulatory requirements. For more
information, see www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170619005644/en/
Philip Morris InternationalMedia OfficeT: +41 (0)58 242
4500E: media@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
From Apr 2023 to Apr 2024